0001209191-14-005682.txt : 20140129 0001209191-14-005682.hdr.sgml : 20140129 20140129194802 ACCESSION NUMBER: 0001209191-14-005682 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20140129 FILED AS OF DATE: 20140129 DATE AS OF CHANGE: 20140129 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Celladon Corp CENTRAL INDEX KEY: 0001305253 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330971591 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 12760 HIGH BLUFF DRIVE STREET 2: SUITE 240 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 858-366-4288 MAIL ADDRESS: STREET 1: 12760 HIGH BLUFF DRIVE STREET 2: SUITE 240 CITY: SAN DIEGO STATE: CA ZIP: 92130 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RUDY JEFFREY J CENTRAL INDEX KEY: 0001590705 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36183 FILM NUMBER: 14558312 MAIL ADDRESS: STREET 1: C/O CELLADON CORPORATION STREET 2: 12760 HIGH BLUFF DRIVE, SUITE 240 CITY: SAN DIEGO STATE: CA ZIP: 92130 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2014-01-29 0 0001305253 Celladon Corp CLDN 0001590705 RUDY JEFFREY J 12760 HIGH BLUFF DRIVE, STE 240 SAN DIEGO CA 92130 0 1 0 0 VP Clinical Operations Stock option (right to buy) 212.33 2016-07-25 Common Stock 40 D Stock option (right to buy) 224.82 2017-07-03 Common Stock 40 D Stock option (right to buy) 224.82 2017-11-13 Common Stock 201 D Stock option (right to buy) 224.82 2018-05-06 Common Stock 55 D Stock option (right to buy) 224.82 2019-03-10 Common Stock 25 D Stock option (right to buy) 224.82 2020-01-14 Common Stock 25 D Stock option (right to buy) 349.72 2020-06-10 Common Stock 98 D Stock option (right to buy) 1.12 2022-06-14 Common Stock 108354 D Stock option (right to buy) 8.00 2024-01-28 Common Stock 30900 D The stock options are fully vested and exercisable. The shares subject to the option vest 1/48th per month beginning one month after April 27, 2010 (the "Vesting Commencement Date") and continue thereafter until the option shall be fully vested and exercisable on the four year anniversary of the Vesting Commencement Date. 25% of the shares subject to the option vested and became exercisable on the one year anniversary of January 27, 2012 (the "Vesting Commencement Date"), and 1/48th of the shares vest in equal monthly intallments thereafter, such that the option shall be fully vested and exercisable on the four year anniversary of the Vesting Commencement Date. 25% of the shares subject to the option shall vest on the one year anniversary of January 29, 2014 (the "Vesting Commencement Date"), and 1/48th of the shares vest in equal monthly intallments thereafter, such that the option shall be fully vested and exercisable on the four year anniversary of the Vesting Commencement Date. /s/ Rebecque Laba, Attorney-in-fact 2014-01-29 EX-24.3_503782 2 poa.txt POA DOCUMENT POWER OF ATTORNEY Know all by these presents, that the undersigned hereby constitutes and appoints each of, Krisztina M. Zsebo, Rebecque J. Laba and Fredrik Wiklund of Celladon Corporation (the "Company"), signing individually, the undersigned's true and lawful attorney-in fact and agent to: (1) execute for and on behalf of the undersigned, an officer, director or holder of 10% of more of a registered class of securities of the Company, Forms 3, 4 and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act") and the rules thereunder; (2) do and perform any and all acts for and on behalf of the undersigned that may be necessary or desirable to complete and execute such Form 3, 4 or 5, complete and execute any amendment or amendments thereto, and timely file such forms or amendments with the United States Securities and Exchange Commission and any stock exchange or similar authority; and (3) take any other action of any nature whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion. The undersigned hereby grants to such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorney-in-fact, in serving in such capacity at the request of the undersigned, is not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Exchange Act. This Power of Attorney shall remain in full force and effect until the earliest to occur of (a) the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, (b) revocation by the undersigned in a signed writing delivered to the foregoing attorney-in-fact or (c) until such attorney-in-fact shall no longer be employed by the Company. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 13th day of November, 2013. /s/ Jeffrey J. Rudy Jeffrey J. Rudy